An Exploratory Basket Study of Pyrotinib Maleate Tablets in HER2 Mutated or Amplified of Metastatic Solid Tumors
NCT05274191
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
Pyrotinib Maleate
OTHER:
standard regimen
Sponsor
Zhongshan Hospital Xiamen University